Search
for
Sort by
Research 451–480 of 1000+
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Ann Robinson’s research reviews —12 May 2022
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Emerging treatments in alopecia
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment
- Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Review of modern methods of treating vitiligo
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib